☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
RESET
Pear Therapeutics Reports the Availability of its Prescription Digital Therapeutics to Wellpath Community Care Centers
September 24, 2020
Pfizer Reports Results of Rivipansel in P-III RESET Study for Sickle Cell Disease with Vaso-Occlusive Crisis
August 5, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.